Conflict of interest declaration: Paul Moayyedi

Roles in: Upper GI and Pancreatic Diseases Group

1. In the past three years have you accepted the following from an organisation that may gain or lose financially from the publication of reviews by your review group in the Cochrane Database of Systematic Reviews (CDSR)?

a) Reimbursement for attending a conference or symposium (including travel, accommodation and/or hospitality)?
No

b) Fees for speaking?
Yes - I have accepted speaker fees from Shire and Allergan. These companies make drugs for IBS and ulcerative colitis and I have not been involved with pharmaceutical companies that sell drugs to treat any upper GI disease.

c) Fees for organising education?
No

d) Funds for research?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
No

g) Royalty payments?
No

2. In the past three years have you or your spouse/partner been employed by an organization that may in any way gain or lose financially from the publication of reviews by your review group in the CDSR?
No

3. Do you own stocks or shares in companies that may gain or lose financially from the publication of reviews by your review group in the CDSR?
No

4. Do you hold any patents for products that that may lead you to gain or lose financially from the publication of reviews by your review group in the CDSR?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - My endowed Chair is funded in part by an unrestricted donation given to McMaster University by AstraZeneca Canada.